Thursday, Nov 30, 2023


These are generic versions of Vimpat tablets of the corresponding strengths of UCB, Inc.

Glenmark Pharmaceuticals Gets USFDA Nod For Lacosamide Tablet

The approval granted by the USFDA to the company's arm Glenmark Pharmaceuticals Inc, USA, is for Lacosamide tablets of strengths 50 mg, 100 mg, 150 mg, and 200 mg.

21 March 2022

Pharmacy in UK offers food to encourage Covid-19 vaccination.(Representational image)

Covid-19: Indian-Origin Brothers In UK Offer Jabs With Kebabs Service

Covid-19: Rav and Raj Chopra, who own popular restaurant Punjabi Grill in Gravesend UK, set up the walk-in vaccine centre after their father became unwell with the virus last year. The two brothers, volunteer for the...

22 January 2022

USFDA Rejects Biocon, Viatris Application For Insulin Aspart

Biocon Biologics, a subsidiary of biotechnology major Biocon, on Friday said the US health regulator has not approved an application for Insulin Aspart filed by its partner Viatris Inc

08 January 2022

Pharmaceutical Sector.

Piramal Pharma Ropes In Ajay Devgn For Brand Tetmosol

Piramal Pharma said it is now strengthening the brand offering by introducing Tetmosol Dusting Powder and increasing its media investments subsequently.

14 March 2022

Strides Pharma's Singapore arm gets USFDA nod for generic version of oseltamivir phosphate

Strides Pharma Science Ltd has received approval from the US health regulator for its generic version of oseltamivir phosphate for oral suspension, used for treating illness due to influenza.

17 January 2022

"Pharmacy Of The World": India Delivers Over 65 Million Doses Of Covid Vaccines To 100 Countries This Year

"Our policy interventions are being made based on wide consultations with all stakeholders". Speaking at inaugurating the first global innovation summit of the pharmaceutical sector, Modi said India's vision is to create an...

18 November 2021

Drugs, medications, antibiotics, pharma, biotics, medicine

Suramin Reduces Drug Resistance In Mycobacteria, Says Study

Strategies to tackle drug-resistant strains include identification of new antibiotics or targeting the bacterial mechanisms that reduce the rate of evolution of resistance, RGCB said.

27 February 2022


The Pharma IPO Boom Continues. Which Ones Will Stand Out?

Despite the muted response to Vijaya Diagnostics IPO, the broader boom is likely to continue on the back of improved financials and the potential of the ‘China plus one’ strategy.

03 September 2021